NDC 58118-1188-08 - buprenorphine hydrochloride and naloxone hydrochloride dihydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58118-1188
- Requested NDC
- 58118-1188-08
- Package NDCs from labels
- 58118-1188-8, 58118-1188-08
- Manufacturer
- Clinical Solutions Wholesale, LLC
- Effective date
- 2026-03-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ANHYDROUS CITRIC ACID - Clinical Solutions Wholesale, LLC | Clinical Solutions Wholesale, LLC | 2026-03-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58118-1188-8 | buprenorphine hydrochloride and naloxone hydrochloride dihydrate | 30 in 1 BLISTER PACK | TABLET | 30 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2026-10-30 | Adverse reactions | XF417D3PSL |
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2026-10-28 | Warnings | B22547B95K |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Buprenorphine hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Gland Pharma Limited | 69ec3405-78ee-4cb4-9180-9bea937a8dcd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Emetrol Chewables | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9880a18a-cf84-47cd-99b5-d692065a25bf | 2026-09-24 | Warnings | B22547B95K |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Golden State Medical Supply, Inc. | 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | 2026-09-21 | Warnings, Adverse reactions | ANDA203326 351266 351267 5Q187997EE 56W8MW3EN1 |
| buprenorphine hydrochloride | BUPRENORPHINE HYDROCHLORIDE | REMEDYREPACK INC. | 9f7b0a28-f937-4d4d-b793-ca3468bd28e0 | 2026-09-17 | Warnings, Adverse reactions | 56W8MW3EN1 |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| BUPRENORPHINE AND NALOXONE | BUPRENORPHINE AND NALOXONE | Major Pharmaceuticals | c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | 2026-09-02 | Warnings, Adverse reactions | ANDA203326 351266 351267 5Q187997EE 56W8MW3EN1 |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | REMEDYREPACK INC. | 4124c4ad-ef62-4c95-8e57-0d843862ae71 | 2026-08-17 | Warnings, Adverse reactions | ANDA203326 351267 5Q187997EE 56W8MW3EN1 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | REMEDYREPACK INC. | 43027750-d218-49e5-867f-c941736d2056 | 2026-08-17 | Warnings, Adverse reactions | ANDA203326 351266 5Q187997EE 56W8MW3EN1 |
| Caring Mill Lubricant Eye Drops | GLYCERIN, POVIDONE | FSA Store Inc | 2f735cdf-6530-1adf-e063-6394a90ab16a | 2026-08-16 | Warnings | FZ989GH94E |
| CVS Health Nausea Relief | SODIUM CITRATE DIHYDRATE | CVS PHARMACY,INC. | a5f9de6f-70d8-4bb0-8a5b-3dd120df2990 | 2026-08-14 | Warnings | B22547B95K |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 58d2c995-c0cf-a007-e063-6394a90a3f77 | 2026-08-12 | Warnings, Adverse reactions | 5Q187997EE 56W8MW3EN1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.